Syndax Pharmaceuticals, Inc. (SNDX)
23.88
+0.52
(+2.23%)
USD |
NASDAQ |
Apr 01, 16:00
24.20
+0.32
(+1.34%)
After-Hours: 20:00
Syndax Pharmaceuticals Research and Development Expense (TTM) : 258.78M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cogent Biosciences, Inc. | 265.16M |
| Vera Therapeutics, Inc. | 214.79M |
| Biogen, Inc. | 1.498B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |